Neogenomics Inc
NASDAQ:NEO

Watchlist Manager
Neogenomics Inc Logo
Neogenomics Inc
NASDAQ:NEO
Watchlist
Price: 16.245 USD -0.64%
Market Cap: 2.1B USD
Have any thoughts about
Neogenomics Inc?
Write Note

Neogenomics Inc
Cash & Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Neogenomics Inc
Cash & Cash Equivalents Peer Comparison

Comparables:
TMO
DHR
MTD
A
IQV

Competitive Cash & Cash Equivalents Analysis
Latest Figures & CAGR of Competitors

Company Cash & Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
Neogenomics Inc
NASDAQ:NEO
Cash & Cash Equivalents
$362m
CAGR 3-Years
2%
CAGR 5-Years
15%
CAGR 10-Years
27%
Thermo Fisher Scientific Inc
NYSE:TMO
Cash & Cash Equivalents
$4.6B
CAGR 3-Years
-27%
CAGR 5-Years
30%
CAGR 10-Years
24%
Danaher Corp
NYSE:DHR
Cash & Cash Equivalents
$2.6B
CAGR 3-Years
1%
CAGR 5-Years
-29%
CAGR 10-Years
-4%
Mettler-Toledo International Inc
NYSE:MTD
Cash & Cash Equivalents
$70.8m
CAGR 3-Years
-21%
CAGR 5-Years
-11%
CAGR 10-Years
-4%
Agilent Technologies Inc
NYSE:A
Cash & Cash Equivalents
$1.8B
CAGR 3-Years
8%
CAGR 5-Years
0%
CAGR 10-Years
-3%
IQVIA Holdings Inc
NYSE:IQV
Cash & Cash Equivalents
$1.6B
CAGR 3-Years
2%
CAGR 5-Years
13%
CAGR 10-Years
9%

See Also

What is Neogenomics Inc's Cash & Cash Equivalents?
Cash & Cash Equivalents
362m USD

Based on the financial report for Sep 30, 2024, Neogenomics Inc's Cash & Cash Equivalents amounts to 362m USD.

What is Neogenomics Inc's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
27%

Over the last year, the Cash & Cash Equivalents growth was 18%. The average annual Cash & Cash Equivalents growth rates for Neogenomics Inc have been 2% over the past three years , 15% over the past five years , and 27% over the past ten years .

Back to Top